Drs. Stolina, Zack, Kostenuik, Feige, and Ms Dwyer own stock or stock options in Amgen Inc.
Experimental Arthritis
You have full text access to this OnlineOpen article
Tumor necrosis factor α and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis
Article first published online: 27 AUG 2009
DOI: 10.1002/art.24767
Copyright © 2009 by the American College of Rheumatology
Additional Information
How to Cite
Schett, G., Stolina, M., Dwyer, D., Zack, D., Uderhardt, S., Krönke, G., Kostenuik, P. and Feige, U. (2009), Tumor necrosis factor α and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis. Arthritis & Rheumatism, 60: 2644–2654. doi: 10.1002/art.24767
Publication History
- Issue published online: 27 AUG 2009
- Article first published online: 27 AUG 2009
- Manuscript Accepted: 26 MAY 2009
- Manuscript Received: 15 OCT 2008
Funded by
- Sonderforschungsbereich. Grant Number: SBF) 643
- Interdisziplinäres Zentrum für Klinische Forschung Erlangen
- Forschergruppe 661 of the Deutsche Forschungsgemeinschaft (DFG)
- Austrian Ministry of Sciences (START Program award)
- SPIRAL consortium, and the EU projects Masterswitch, Kinacept
- Adipoa
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , Insights into the pathophysiology of ankylosing spondylitis: Contributions from animal models, Joint Bone Spine, 2012, 79, 3, 243
- 2, , Un aperçu de la physiopathologie de la spondylarthrite ankylosante : contribution des modèles animaux, Revue du Rhumatisme, 2012, 79, 1, 11
- 3, , , Advances in Rheumatoid Arthritis Animal Models, Current Rheumatology Reports, 2011, 13, 5, 456
- 4, , , , , , , , , , Alternative for Anti-TNF Antibodies for Arthritis Treatment, Molecular Therapy, 2011, 19, 10, 1887
- 5
- 6
- 7, Structural Bone Changes in Spondyloarthritis: Mechanisms, Clinical Impact and Therapeutic Considerations, The American Journal of the Medical Sciences, 2011, 341, 4, 269
- 8, The balance of tissue repair and remodeling in chronic arthritis, Nature Reviews Rheumatology, 2011, 7, 12, 700
- 9, , , Are current available therapies disease-modifying in spondyloarthritis?, Best Practice & Research Clinical Rheumatology, 2010, 24, 5, 625
- 10, , Can we stop progression of ankylosing spondylitis?, Best Practice & Research Clinical Rheumatology, 2010, 24, 3, 363
- 11, , Novel targets in bone and cartilage, Best Practice & Research Clinical Rheumatology, 2010, 24, 4, 489
- 12
- 13, Bone: Bony spur formation in inflammatory arthritis: an active and independent process, Nature Reviews Rheumatology, 2009, 5, 11, 589

1529-0131/asset/olbannerleft.gif?v=1&s=897b81612b4ad6cae003112184adc709261d5f61)
1529-0131/asset/olbannerright.gif?v=1&s=04654f5ea3cbb01656383e0c0d04b16fd0a9a896)
